...
首页> 外文期刊>Inorganica Chimica Acta >Zn thiosacharinates: From ionic to polymeric structures. Synthesis, characterization and cell proliferation inhibition studies
【24h】

Zn thiosacharinates: From ionic to polymeric structures. Synthesis, characterization and cell proliferation inhibition studies

机译:Zn Thiosacharinates:从离子到聚合物结构。 合成,表征和细胞增殖抑制研究

获取原文
获取原文并翻译 | 示例
           

摘要

A series of Zn thiosacharinates complexes with nitrogen donor co-ligands were synthesized: [Zn(tsac)(2) (o-phen)], [Zn(tsac)(2)(TMDP)](n), [(4,4'-bipy)H-2][Zn(tsac)(4)] ]Zn(tsac)(2)(2,2'-bipy)], ]Zn(tsac)(2)(2,2'-bquin)], (tsac, thiosaccharinate anion: l,l-dioxo-l,2-benzisothiazole-3-thiolato, C7H4NO2S2, o-phen: 1,10'phenantrohne, TMDP: trimethylenedipyridine, 2,2'-bipy: 2,2'-bipyridine, 4,4'-bipy: 4,4'-bipyridine, 2,2'bquin: 2,2'-biquinolme). They were fully characterized by means of FTIR, C-13 and H-1 NMR, elemental analysis and conductivity measurements. Three of them, [Zn(tsac)(2)(o-phen)], ](4,4'-bipy)H-2][Zn(tsac)(4)], [Zn(tsac)(2)(TMDP)](n) were also characterized by X-ray single crystal diffractometry and their crystal structures are described herein. DFT geometry optimization for the [Zn(tsac)(2)(o-phen)] complex was performed and its vibrational spectra was predicted. Moreover, we studied the effects of the five complexes on cell proliferation, thus providing preliminary evidence for their therapeutic potential as anti-cancer drugs. (C) 2018 Elsevier B.V. All rights reserved.
机译:合成了一系列具有氮供体共配体的Zn硫代综合物复合物:[Zn(TSAC)(2)(2)(O-Phen)],[Zn(TSAC)(2)(2)(TMDP)](N),[(4, 4'-Bipy)H-2] [Zn(TSAC)(4)]] Zn(Tsac)(2)(2)(2,2'-Bipy)],] Zn(Tsac)(2)(2)(2,2'-咔氏),(TSAC,Thiosachinate阴离子:L,L-DiOxO-L,2-苯并异噻唑-3-硫醇,C7H4NO2S2,O-Phen:1,10'phenantrohne,TMDP:三甲基吡啶,2,2'-Bipy:2 ,2'-Biphyridine,4,4'-Bipy:4,4'-Biphyridine,2,2'Bquin:2,2'-Biquinolme)。它们通过FTIR,C-13和H-1 NMR,元素分析和电导率测量完全表征。其中三个,[Zn(TSAC)(2)(O-Phen)],](4,4'-Bipy)H-2] [Zn(TSAC)(4)],[Zn(TSAC)(2) (TMDP)](N)还表征,其特征在于X射线单晶衍射法,本文描述了它们的晶体结构。对[Zn(TSAC)(2)(2)(2)(O-Phen)]复合物进行DFT几何优化,并预测其振动光谱。此外,我们研究了五种复合物对细胞增殖的影响,从而为其治疗潜力作为抗癌药物提供初步证据。 (c)2018年elestvier b.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号